CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
AddLife AB Company Snapshot
AddLife AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AddLife AB with three other miscellaneous service companies in Europe: Genus plc of UNITED KINGDOM (2019 sales of £488.50 million [US$650.47 million] of which 52% was Operating Genus PIC), Bachem Holding AG of SWITZERLAND (313.72 million Swiss Francs [US$343.61 million] of which 88% was Active Pharmaceutical Ingredients), and GW Pharmaceuticals PLC which is based in UNITED KINGDOM (£243.39 million [US$324.09 million] of which 100% was Novel Therapeutics).

Sales Analysis. AddLife AB reported sales of SEK 3.48 billion (US$403.12 million) for the year ending December of 2019. This represents an increase of 40.2% versus 2018, when the company's sales were SEK 2.48 billion. Sales at AddLife AB have increased during each of the previous five years (and since 2014, sales have increased a total of 254%). Sales of Medtech saw an increase of 45.4% in 2019, from SEK 1.03 billion to SEK 1.50 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
AddLife AB
  Stock Performance Chart for AddLife AB
 
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 125.64
(Figures in Swedish Kronor)
1 Week -0.3%   13 Weeks -21.5%  
4 Weeks -15.5%   52 Weeks 101.8%  
 
AddLife AB Key Data:
  Ticker: ALIF B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 3,479,400,000
(Year Ending Jan 2020).
Employees: 932
  Currency: Swedish Kronor Market Cap: 14,102,107,746
  Fiscal Yr Ends: December Shares Outstanding: 112,242,182
  Share Type: AKTIE Closely Held Shares: 17,603,505
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.